These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6137230)

  • 21. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic blood flow: accuracy of estimation from infusions of indocyanine green in anaesthetized cats.
    Burczynski FJ; Greenway CV; Sitar DS
    Br J Pharmacol; 1987 Jul; 91(3):651-9. PubMed ID: 3607371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.
    Herz R; Rössle M; Bonzel T; Keller E; Gerok W
    Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
    Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
    Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of indocyanine green in rats with experimentally induced hepatic diseases.
    Kimura T; Nakayama S; Yamao T; Kurosaki Y; Nakayama T
    Biol Pharm Bull; 1993 Nov; 16(11):1140-5. PubMed ID: 8312872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR; El-Desoky AA; Seifalian AM; Habib N; Davidson BR
    Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental study of liver dysfunction evaluated by direct indocyanine green clearance using near infrared spectroscopy.
    El-Desoky A; Seifalian AM; Cope M; Delpy DT; Davidson BR
    Br J Surg; 1999 Aug; 86(8):1005-11. PubMed ID: 10460634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.
    Merkel C; Bolognesi M; Finucci GF; Angeli P; Caregaro L; Rondana M; Gatta A
    J Hepatol; 1989 Jul; 9(1):16-22. PubMed ID: 2768794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of ranitidine on hepatic blood flow assessed by organ-reflectance spectrophotometer and pulse-Doppler ultrasonic flowmeter.
    Sasaki Y; Hayashi N; Kasahara A; Matsuda Y; Furusawa S; Fusamoto H; Sato N; Kamada T
    Dig Dis Sci; 1985 Nov; 30(11):1043-8. PubMed ID: 2932322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.
    Henry DA; Macdonald IA; Kitchingman G; Bell GD; Langman MJ
    Br Med J; 1980 Sep; 281(6243):775-7. PubMed ID: 6107157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of H2 receptor blocking agents on the liver circulation].
    Drapers JA; van Boxtel CJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Jun; 129(22):1028-30. PubMed ID: 2861573
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
    Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man.
    Skak C; Keiding S
    Liver; 1987 Jun; 7(3):155-62. PubMed ID: 3613884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
    Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
    Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E1 increases indocyanine green disappearance rate in patients with chronic liver disease.
    Aono T; Sakaguchi T; Tsukada K; Fujita N; Ishiduka D; Hatakeyama K
    J Int Med Res; 1995; 23(4):299-307. PubMed ID: 7589774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
    Ohnishi K
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():6-10. PubMed ID: 2210613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine has no influence on tubular creatinine secretion.
    van den Berg JG; Koopman MG; Arisz L
    Nephron; 1996; 74(4):705-8. PubMed ID: 8956305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.